| [1] |
Liu XC, Mei FJ, Fang M, et al. Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases[J]. Front Oncol, 2024, 13: 1322635. DOI: 10.3389/fonc.2023.1322635.
|
| [2] |
Remon J, Le Rhun E, Besse B. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era[J]. Cancer Treat Rev, 2017, 53: 128-137. DOI: 10.1016/j.ctrv.2016.12.006.
pmid: 28110254
|
| [3] |
Thakkar JP, Kumthekar P, Dixit KS, et al. Leptomeningeal metastasis from solid tumors[J]. J Neurol Sci, 2020, 411: 116706. DOI: 10.1016/j.jns.2020.116706.
|
| [4] |
徐燕, 李龙芸, 王孟昭. 非小细胞肺癌脑膜转移诊疗现状[J]. 中国肺癌杂志, 2015, 18(10): 626-632. DOI: 10.3779/j.issn.1009-3419.2015.10.05.
|
| [5] |
White MD, Klein RH, Shaw B, et al. Detection of leptomeningeal disease using cell-free DNA from cerebrospinal fluid[J]. JAMA Netw Open, 2021, 4(8): e2120040. DOI: 10.1001/jamanetworkopen.2021.20040.
|
| [6] |
Angus L, Deger T, Jager A, et al. Detection of aneuploidy in cerebrospinal fluid from patients with breast cancer can improve diagnosis of leptomeningeal metastases[J]. Clin Cancer Res, 2021, 27(10): 2798-2806. DOI: 10.1158/1078-0432.CCR-20-3954.
pmid: 33514525
|
| [7] |
Taillibert S, Chamberlain MC. Leptomeningeal metastasis[J]. Handb Clin Neurol, 2018, 149: 169-204. DOI: 10.1016/B978-0-12-811161-1.00013-X.
pmid: 29307353
|
| [8] |
罗毅君, 姚伟荣, 王晓莉. EGFR突变非小细胞肺癌脑转移靶向治疗进展[J]. 国际肿瘤学杂志, 2024, 51(11): 717-722. DOI: 10.3760/cma.j.cn371439-20240318-00121.
|
| [9] |
Jia C, Xu Q, Zhao L, et al. Therapeutic role of EGFR-tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis[J]. Transl Oncol, 2024, 39: 101832. DOI: 10.1016/j.tranon.2023.101832.
|
| [10] |
Kodama T, Hasegawa M, Takanashi K, et al. Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases[J]. Cancer Chemother Pharmacol, 2014, 74(5): 1023-1028. DOI: 10.1007/s00280-014-2578-6.
|
| [11] |
Fujiwara Y, Masago K, Matsuzawa R, et al. Long-term response of lorlatinib to leptomeningeal metastasis in patients with anaplastic lymphoma kinase fusion positive non-small lung cancer: a case report[J]. Case Rep Oncol, 2024, 17(1): 942-949. DOI: 10.1159/000540445.
pmid: 39474536
|
| [12] |
Fan Y, Qin J, Han N, et al. HER2 exon 20 insertion mutations in lung adenocarcinoma with leptomeningeal metastasis: a case report and response to poziotinib[J]. Ann Palliat Med, 2022, 11(4): 1582-1588. DOI: 10.21037/apm-21-213.
|
| [13] |
Zheng MM, Tu HY, Yang JJ, et al. Clinical outcomes of non-small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments[J]. Eur J Cancer, 2021, 150: 23-30. DOI: 10.1016/j.ejca.2021.03.037.
|
| [14] |
Wang Y, Yang X, Li NJ, et al. Leptomeningeal metastases in non-small cell lung cancer: diagnosis and treatment[J]. Lung Cancer, 2022, 174: 1-13. DOI: 10.1016/j.lungcan.2022.09.013.
pmid: 36206679
|
| [15] |
谢宇, 郑胜男, 黄明敏, 等. 基于脑脊液药代动力学的培美曲塞应用于肺腺癌软脑膜转移患者鞘内注射化疗的临床研究[J]. 国际肿瘤学杂志, 2023, 50(10): 585-591. DOI: 10.3760/cma.j.cn371439-20230612-00112.
|
| [16] |
Patil S, Rathnum KK. Management of leptomeningeal metastases in non-small cell lung cancer[J]. Indian J Cancer, 2019, 56(Suppl 1): S1-S9. DOI: 10.4103/ijc.ijc_74_19.
|
| [17] |
Hosoda T, Katayama M. Epidemiology and prognosis of ommaya reservoir-related bacterial meningitis in adult patients with leptomeningeal metastases from solid tumors: a 10-year retrospective single-center study in Japan[J]. J Infect Chemother, 2021, 27(3): 486-491. DOI: 10.1016/j.jiac.2020.10.025.
pmid: 33214071
|
